Compared side by side
Enclomiphene vs gonadorelin: how they differ
The short answer
Both aim to raise the body’s own LH and FSH, by different routes: enclomiphene is an oral SERM (not a peptide) that blocks estrogen’s negative feedback at the hypothalamus, while gonadorelin is synthetic GnRH injected 2–3 times a week to stimulate the pituitary directly. Enclomiphene is taken daily as a TRT alternative or after a steroid cycle; gonadorelin is mostly run alongside TRT with the aim of keeping testicular function, a use no published trial has tested. In phase 3 trials enclomiphene raised testosterone while largely keeping sperm production, but it isn’t approved anywhere.
Side by side
| Compared | Enclomiphene | Gonadorelin |
|---|---|---|
| Category | Sexual health | Sexual health |
| Also known as | Androxal, Trans-clomiphene, Enclomiphene citrate | GnRH, Gonadotropin-releasing hormone, Gonadorelin acetate |
| What it is | An oral medication that blocks estrogen's negative feedback at the hypothalamus, tricking your brain into producing more LH and FSH — which stimulates your body's own testosterone production. | A synthetic version of the hormone your hypothalamus uses to signal your pituitary to release LH and FSH — the hormones that drive testosterone production and fertility. |
| How it works | Selective estrogen receptor modulator (SERM) and the pure trans-isomer of clomiphene. Blocks estrogen negative feedback at the hypothalamus, increasing LH and FSH production which stimulates endogenous testosterone production. Designed to cause fewer estrogenic side effects than clomifene citrate, since it lacks the estrogenic zuclomiphene isomer (no head-to-head trial). SERM, not a peptide — included as it is commonly used in hormonal optimization and TRT-adjacent protocols. | Synthetic GnRH (identical to the natural hormone) that stimulates pituitary release of LH and FSH. Used alongside TRT with the aim of maintaining testicular function, testosterone production and fertility; that use hasn't been tested in trials. Continuous exposure (an infusion or long-acting GnRH drugs) shuts the axis down, while intermittent injections of short-lived gonadorelin stimulate it; 2–3x weekly is the common clinic schedule. |
| Commonly reported | Better energy and libido over a few weeks as testosterone rises, mood changes such as irritability in some, and occasional visual disturbances that make some people stop. Used as a TRT alternative or in post-cycle therapy (PCT) to restart natural testosterone. | Some users on TRT say it helps keep testicular size and fullness compared with TRT alone, and many describe it as weaker than hCG. It's usually injected 2–3 times a week; what shuts the system down is constant exposure (like a drip or long-acting GnRH drugs), not daily use. |
| Studied range | Research range: 12.5–25 mg. Studied in research — not a recommendation. | Research range: 100 mcg. Studied in research — not a recommendation. |
| How often | Daily | 2–3x weekly (pulsatile) |
| Half-life | ~10 hours | ~2–10 min |
| Route | Oral | SubQ injection |
| Typical run | Daily oral. Used for months in clinical context. Community uses in 3–6 month cycles. Also used as an alternative to TRT (its trials compared it with testosterone gel) and, in the community, after a steroid cycle (PCT). | Used continuously alongside TRT with the aim of maintaining testicular function, typically 2–3x/week ongoing. |
| Evidence | Moderate: animal studies + some human data | Established: clinical trials or FDA-approved use exists |
| Common side effects | Mood changes, visual disturbances (rare), hot flashes, blood-clot risk flagged by the EU regulator | Generally well tolerated, injection site reactions, headache |
- Category
- EnclomipheneSexual health
- GonadorelinSexual health
- Also known as
- EnclomipheneAndroxal, Trans-clomiphene, Enclomiphene citrate
- GonadorelinGnRH, Gonadotropin-releasing hormone, Gonadorelin acetate
- What it is
- EnclomipheneAn oral medication that blocks estrogen's negative feedback at the hypothalamus, tricking your brain into producing more LH and FSH — which stimulates your body's own testosterone production.
- GonadorelinA synthetic version of the hormone your hypothalamus uses to signal your pituitary to release LH and FSH — the hormones that drive testosterone production and fertility.
- How it works
- EnclomipheneSelective estrogen receptor modulator (SERM) and the pure trans-isomer of clomiphene. Blocks estrogen negative feedback at the hypothalamus, increasing LH and FSH production which stimulates endogenous testosterone production. Designed to cause fewer estrogenic side effects than clomifene citrate, since it lacks the estrogenic zuclomiphene isomer (no head-to-head trial). SERM, not a peptide — included as it is commonly used in hormonal optimization and TRT-adjacent protocols.
- GonadorelinSynthetic GnRH (identical to the natural hormone) that stimulates pituitary release of LH and FSH. Used alongside TRT with the aim of maintaining testicular function, testosterone production and fertility; that use hasn't been tested in trials. Continuous exposure (an infusion or long-acting GnRH drugs) shuts the axis down, while intermittent injections of short-lived gonadorelin stimulate it; 2–3x weekly is the common clinic schedule.
- Commonly reported
- EnclomipheneBetter energy and libido over a few weeks as testosterone rises, mood changes such as irritability in some, and occasional visual disturbances that make some people stop. Used as a TRT alternative or in post-cycle therapy (PCT) to restart natural testosterone.
- GonadorelinSome users on TRT say it helps keep testicular size and fullness compared with TRT alone, and many describe it as weaker than hCG. It's usually injected 2–3 times a week; what shuts the system down is constant exposure (like a drip or long-acting GnRH drugs), not daily use.
- Studied range
- EnclomipheneResearch range: 12.5–25 mg. Studied in research — not a recommendation.
- GonadorelinResearch range: 100 mcg. Studied in research — not a recommendation.
- How often
- EnclomipheneDaily
- Gonadorelin2–3x weekly (pulsatile)
- Half-life
- Enclomiphene~10 hours
- Gonadorelin~2–10 min
- Route
- EnclomipheneOral
- GonadorelinSubQ injection
- Typical run
- EnclomipheneDaily oral. Used for months in clinical context. Community uses in 3–6 month cycles. Also used as an alternative to TRT (its trials compared it with testosterone gel) and, in the community, after a steroid cycle (PCT).
- GonadorelinUsed continuously alongside TRT with the aim of maintaining testicular function, typically 2–3x/week ongoing.
- Evidence
- EnclomipheneModerate: animal studies + some human data
- GonadorelinEstablished: clinical trials or FDA-approved use exists
- Common side effects
- EnclomipheneMood changes, visual disturbances (rare), hot flashes, blood-clot risk flagged by the EU regulator
- GonadorelinGenerally well tolerated, injection site reactions, headache
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
Enclomiphene
- Day 1–14 LH and FSH climbing, T follows
- Day 14–84 Steady-state testosterone
- Day 84–180 Long-term use assessment
Gonadorelin
- Day 1–14 Settling into the cadence
- Day 14–84 Testicular function holding
- Day 84–365 Long-term maintenance pattern
Together or one or the other
Enclomiphene and gonadorelin are a common stack: enclomiphene lists gonadorelin among its common stacks.
Questions people ask
How long do enclomiphene and gonadorelin last?
The half-life of enclomiphene is ~10 hours. The half-life of gonadorelin is ~2–10 min.
How often are enclomiphene and gonadorelin taken?
Enclomiphene: daily. Route: Oral. Gonadorelin: 2–3x weekly (pulsatile). Route: SubQ injection.
How are enclomiphene and gonadorelin dosed in research?
The research range for enclomiphene is 12.5–25 mg. The research range for gonadorelin is 100 mcg. Studied in research — not a recommendation.
What are the common side effects of enclomiphene and gonadorelin?
For enclomiphene, the library lists: mood changes, visual disturbances (rare), hot flashes, blood-clot risk flagged by the EU regulator. For gonadorelin: generally well tolerated, injection site reactions, headache.
Are enclomiphene and gonadorelin taken together?
Enclomiphene and gonadorelin are a common stack: enclomiphene lists gonadorelin among its common stacks.